Balyasny Asset Management’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-71,791
| Closed | -$8.61M | – | 3300 |
|
|
2025
Q3 | $8.61M | Buy |
+71,791
| New | +$9.1M | 0.01% | 1126 |
|
|
2024
Q3 | – | Sell |
-41,814
| Closed | -$4.97M | – | 2926 |
|
|
2024
Q2 | $4.97M | Sell |
41,814
-27,554
| -40% | -$2.9M | 0.01% | 1174 |
|
|
2024
Q1 | $7.44M | Sell |
69,368
-2,157
| -3% | -$214K | 0.01% | 1063 |
|
|
2023
Q4 | $7.13M | Buy |
71,525
+37,675
| +111% | +$3.68M | 0.01% | 992 |
|
|
2023
Q3 | $4.03M | Buy |
33,850
+27,433
| +428% | +$4.09M | 0.01% | 1173 |
|
|
2023
Q2 | $1.14M | Buy |
+6,417
| New | +$1.18M | ﹤0.01% | 1569 |
|
|
2021
Q4 | – | Sell |
-88,476
| Closed | -$20.6M | – | 2406 |
|
|
2021
Q3 | $20.6M | Buy |
+88,476
| New | +$18.6M | 0.09% | 335 |
|
|
2021
Q2 | – | Sell |
-54,779
| Closed | -$11.3M | – | 2138 |
|
|
2021
Q1 | $11.3M | Buy |
+54,779
| New | +$11.6M | 0.06% | 448 |
|
|
2020
Q2 | – | Sell |
-36,735
| Closed | -$7.41M | – | 1296 |
|
|
2020
Q1 | $7.41M | Sell |
36,735
-74,014
| -67% | -$14.2M | 0.09% | 309 |
|
|
2019
Q4 | $20.7M | Buy |
+110,749
| New | +$19.1M | 0.12% | 256 |
|
|
2019
Q2 | – | Sell |
-57,984
| Closed | -$13.9M | – | 1589 |
|
|
2019
Q1 | $13.9M | Buy |
57,984
+52,290
| +918% | +$12.5M | 0.09% | 308 |
|
|
2018
Q4 | $1.31M | Sell |
5,694
-1,629
| -22% | -$402K | 0.01% | 821 |
|
|
2018
Q3 | $2.07M | Buy |
7,323
+2,116
| +41% | +$620K | 0.01% | 963 |
|
|
2018
Q2 | $1.53M | Buy |
5,207
+3,220
| +162% | +$880K | 0.01% | 1023 |
|
|
2018
Q1 | $502K | Buy |
+1,987
| New | +$467K | ﹤0.01% | 1445 |
|
|
2017
Q4 | – | Sell |
-7,457
| Closed | -$1.39M | – | 2165 |
|
|
2017
Q3 | $1.39M | Buy |
+7,457
| New | +$1.3M | 0.01% | 1081 |
|
|
2017
Q1 | – | Sell |
-91,451
| Closed | -$13.5M | – | 1674 |
|
|
2016
Q4 | $13.5M | Sell |
91,451
-643
| -0.7% | -$93.1K | 0.07% | 391 |
|
|
2016
Q3 | $11.6M | Sell |
92,094
-118,771
| -56% | -$14.3M | 0.07% | 360 |
|
|
2016
Q2 | $23.8M | Buy |
210,865
+83,909
| +66% | +$8.71M | 0.15% | 169 |
|
|
2016
Q1 | $13.2M | Sell |
126,956
-113,892
| -47% | -$10.9M | 0.08% | 326 |
|
|
2015
Q4 | $27.2M | Buy |
240,848
+81,711
| +51% | +$9.03M | 0.19% | 157 |
|
|
2015
Q3 | $17.4M | Sell |
159,137
-205,692
| -56% | -$22M | 0.13% | 217 |
|
|
2015
Q2 | $34.9M | Buy |
364,829
+208,286
| +133% | +$19.5M | 0.21% | 117 |
|
|
2015
Q1 | $14.6M | Buy |
+156,543
| New | +$13.7M | 0.12% | 261 |
|
|
2014
Q4 | – | Sell |
-57,398
| Closed | -$3.68M | – | 737 |
|
|
2014
Q3 | $3.68M | Buy |
+57,398
| New | +$3.52M | 0.03% | 517 |
|
|
2014
Q2 | – | Sell |
-25,810
| Closed | -$1.55M | – | 689 |
|
|
2014
Q1 | $1.55M | Buy |
+25,810
| New | +$1.59M | 0.02% | 497 |
|
Other funds holding ICUI
RRAM
Balyasny Asset Management's ICUI Position: Q4 2025 in Review
Balyasny Asset Management sold out of ICU Medical (ICUI) in Q4 2025, closing a stake of 71,791 shares — an estimated $8.61M sold.
Balyasny Asset Management first reported a position in ICUI in Q1 2014 and held it in 26 quarters. The position peaked at $34.9M in Q2 2015. 291 funds tracked by Wall St. Rank hold ICUI as of Q4 2025.
- Balyasny Asset Management reported no remaining ICU Medical position as of Q4 2025 after selling out during the quarter.
- Balyasny Asset Management sold 71,791 ICU Medical shares in Q4 2025, an estimated $8.61M.
- Balyasny Asset Management first reported a position in ICU Medical in Q1 2014 and held it in 26 quarters.
- Balyasny Asset Management's ICU Medical position peaked at $34.9M in Q2 2015.
- 291 funds tracked by Wall St. Rank held ICU Medical as of Q4 2025.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.